Latest & greatest articles for corticosteroids

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on corticosteroids or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on corticosteroids and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for corticosteroids

121. Antiviral Agents Added to Corticosteroids for Early Treatment of Adults With Acute Idiopathic Facial Nerve Paralysis (Bell Palsy).

Antiviral Agents Added to Corticosteroids for Early Treatment of Adults With Acute Idiopathic Facial Nerve Paralysis (Bell Palsy). CLINICAL QUESTION: Compared with oral corticosteroids alone, are oral antiviral drugs associated with improved outcomes when combined with oral corticosteroids in patients presenting within 72 hours of the onset of Bell palsy? BOTTOM LINE: Compared with oral corticosteroids alone, the addition of acyclovir, valacyclovir, or famcyclovir to oral corticosteroids for

JAMA2016

122. Psoriasis patients’ experiences concerning medical adherence to treatment with topical corticosteroids

Psoriasis patients’ experiences concerning medical adherence to treatment with topical corticosteroids 29387598 2018 11 13 2230-326X 6 2016 Psoriasis (Auckland, N.Z.) Psoriasis (Auckl) Psoriasis patients' experiences concerning medical adherence to treatment with topical corticosteroids. 113-119 10.2147/PTT.S109557 Nonadherence to topical treatment of psoriasis is a common cause of treatment failure. This focus group study was conducted to obtain the patients' own experiences and explanations (...) regarding medical adherence. The participants consisted of eight primary adherent patients with moderate psoriasis treated with corticosteroid or corticosteroid-calcipotriol combinations, purposefully sampled by age and sex at a dermatology outpatient clinic. Secondary medical adherence was supported by accessibility of the prescribing physician, the prescriber taking time to listen, having a more manageable disease, using a nonstaining product, and establishing routines around treatment at home

Psoriasis (Auckland, N.Z.)2016 Full Text: Link to full Text with Trip Pro

123. Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial.

Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial. BACKGROUND: Non-infectious uveitis is a potentially sight-threatening ocular disorder caused by chronic inflammation and its complications. Therapeutic success is limited by systemic adverse effects associated with long-term corticosteroid and immunomodulator use if topical medication (...) is not sufficient to control the inflammation. We aimed to assess the efficacy and safety of adalimumab in patients with inactive, non-infectious uveitis controlled by systemic corticosteroids. METHODS: We did this multicentre, double-masked, randomised, placebo-controlled phase 3 trial at 62 study sites in 21 countries in the USA, Canada, Europe, Israel, Australia, and Latin America. Patients (aged ≥18 years) with inactive, non-infectious intermediate, posterior, or panuveitic uveitis controlled by 10-35 mg

Lancet2016

124. Combination Inhaled Corticosteroids and Long-Acting Beta2-Agonists for Acute Respiratory Tract Infections and Cough: A Review of the Clinical Effectiveness

Combination Inhaled Corticosteroids and Long-Acting Beta2-Agonists for Acute Respiratory Tract Infections and Cough: A Review of the Clinical Effectiveness Combination Inhaled Corticosteroids and Long-Acting Beta2-Agonists for Acute Respiratory Tract Infections and Cough: A Review of the Clinical Effectiveness | CADTH.ca Find the information you need Combination Inhaled Corticosteroids and Long-Acting Beta2-Agonists for Acute Respiratory Tract Infections and Cough: A Review of the Clinical (...) Effectiveness Combination Inhaled Corticosteroids and Long-Acting Beta2-Agonists for Acute Respiratory Tract Infections and Cough: A Review of the Clinical Effectiveness Published on: July 6, 2016 Project Number: RC0790-000 Product Line: Research Type: Drug Report Type: Summary with Critical Appraisal Result type: Report Question What is the clinical effectiveness of combination inhaled corticosteroids (ICSs) and long-acting beta2-agonists (LABAs) for patients with acute bacterial upper respiratory tract

Canadian Agency for Drugs and Technologies in Health - Rapid Review2016

125. Combination Inhaled Corticosteroids and Long-Acting Beta2-Agonists for Acute Respiratory Tract Infections and Cough: Clinical Effectiveness

Combination Inhaled Corticosteroids and Long-Acting Beta2-Agonists for Acute Respiratory Tract Infections and Cough: Clinical Effectiveness Combination Inhaled Corticosteroids and Long-Acting Beta2-Agonists for Acute Respiratory Tract Infections and Cough: Clinical Effectiveness | CADTH.ca Find the information you need Combination Inhaled Corticosteroids and Long-Acting Beta2-Agonists for Acute Respiratory Tract Infections and Cough: Clinical Effectiveness Combination Inhaled Corticosteroids (...) and Long-Acting Beta2-Agonists for Acute Respiratory Tract Infections and Cough: Clinical Effectiveness Published on: June 15, 2016 Project Number: RB0996-000 Product Line: Research Type: Drug Report Type: Summary of Abstracts Result type: Report Question What is the clinical effectiveness of combination inhaled corticosteroids and long-acting beta2-agonists for patients with acute bacterial upper respiratory tract infections? What is the clinical effectiveness of combination inhaled

Canadian Agency for Drugs and Technologies in Health - Rapid Review2016

126. Corticosteroid exposure in pediatric acute respiratory distress syndrome

Corticosteroid exposure in pediatric acute respiratory distress syndrome PEDSCCM.org Criteria abstracted from series in Review Posted: founded 1995 Questions or comments?

PedsCCM Evidence-Based Journal Club2016

127. Intensive Enteral Nutrition Is Ineffective for Patients With Severe Alcoholic Hepatitis Treated With Corticosteroids

Intensive Enteral Nutrition Is Ineffective for Patients With Severe Alcoholic Hepatitis Treated With Corticosteroids 26764182 2016 03 26 2016 08 08 2016 03 26 1528-0012 150 4 2016 Apr Gastroenterology Gastroenterology Intensive Enteral Nutrition Is Ineffective for Patients With Severe Alcoholic Hepatitis Treated With Corticosteroids. 903-10.e8 10.1053/j.gastro.2015.12.038 S0016-5085(15)01866-1 Severe alcoholic hepatitis (AH) is a life-threatening disease for which adequate oral nutritional (...) support is recommended. We performed a randomized controlled trial to determine whether the combination of corticosteroid and intensive enteral nutrition therapy is more effective than corticosteroid therapy alone in patients with severe AH. We enrolled 136 heavy consumers of alcohol (age, 18-75 y) with recent onset of jaundice and biopsy-proven severe AH in our study, performed at 18 hospitals in Belgium and 2 in France, from February 2010 through February 2013. Subjects were assigned randomly (1:1

EvidenceUpdates2016

128. Corticosteroids, the oldest agent in the prevention of chemotherapy-induced nausea and vomiting: What about the guidelines?

Corticosteroids, the oldest agent in the prevention of chemotherapy-induced nausea and vomiting: What about the guidelines? 28191518 2018 11 13 2450-131X 4 1 2016 Apr 01 Journal of translational internal medicine J Transl Int Med Corticosteroids, the oldest agent in the prevention of chemotherapy-induced nausea and vomiting: What about the guidelines? 46-51 10.1515/jtim-2016-0010 Chemotherapy-induced nausea and vomiting (CINV) remains one of the most disturbing side effects of cancer treatment (...) . Research in antiemetic therapy has progressed gradually since the early eighties, and the development of antiemetic agents continues. This review focuses on the current management of CINV based on the most recent guidelines, and adherence to the latter is examined more carefully. Setrons (5HT3 receptor antagonists), corticosteroids, and NK-1 receptor antagonists are the cornerstones of antiemetic therapy. Corticosteroids are one of the oldest agents in the prevention of CINV. They are highly effective

Journal of translational internal medicine2016 Full Text: Link to full Text with Trip Pro

129. Left ventricular systolic dysfunction in two patients with ankylosing spondylitis: What is the role of corticosteroids?

Left ventricular systolic dysfunction in two patients with ankylosing spondylitis: What is the role of corticosteroids? 28149663 2018 11 13 2147-9720 3 4 2016 Dec European journal of rheumatology Eur J Rheumatol Left ventricular systolic dysfunction in two patients with ankylosing spondylitis: What is the role of corticosteroids? 179-181 10.5152/eurjrheum.2016.15069 Ankylosing spondylitis (AS) is a chronic inflammatory condition that most commonly affects the axial skeleton. The most common (...) , Tehran, Iran. Navid Hossein H Department of Heart Failure and Transplantation, Rajaei Cardiovascular, Medical and Research Center, Iran, University of Medical Sciences, Tehran, Iran. eng Journal Article 2016 04 05 Turkey Eur J Rheumatol 101656068 2147-9720 Ankylosing spondylitis corticosteroids systolic dysfunction No conflict of interest was declared by the authors. 2015 08 28 2015 10 14 2017 2 3 6 0 2017 2 6 6 0 2017 2 6 6 1 ppublish 28149663 10.5152/eurjrheum.2016.15069 ejr-3-4-179 PMC5283567

European journal of rheumatology2016 Full Text: Link to full Text with Trip Pro

131. The impact of including corticosteroid in a periarticular injection for pain control after total knee arthroplasty: a double-blind randomised controlled trial

The impact of including corticosteroid in a periarticular injection for pain control after total knee arthroplasty: a double-blind randomised controlled trial 26850424 2016 02 06 2016 06 20 2016 03 02 2049-4408 98-B 2 2016 Feb The bone & joint journal Bone Joint J The impact of including corticosteroid in a periarticular injection for pain control after total knee arthroplasty: a double-blind randomised controlled trial. 194-200 10.1302/0301-620X.98B2.36596 There is conflicting evidence about (...) the benefit of using corticosteroid in periarticular injections for pain relief after total knee arthroplasty (TKA). We carried out a double-blinded, randomised controlled trial to assess the efficacy of using corticosteroid in a periarticular injection to control pain after TKA. A total of 77 patients, 67 women and ten men, with a mean age of 74 years (47 to 88) who were about to undergo unilateral TKA were randomly assigned to have a periarticular injection with or without corticosteroid. The primary

EvidenceUpdates2016 Full Text: Link to full Text with Trip Pro

132. Oral and inhaled corticosteroid use and risk of recurrent pulmonary embolism

Oral and inhaled corticosteroid use and risk of recurrent pulmonary embolism 26897283 2016 04 06 2016 12 20 2016 12 30 1879-2472 140 2016 Apr Thrombosis research Thromb. Res. Oral and inhaled corticosteroid use and risk of recurrent pulmonary embolism. 46-50 10.1016/j.thromres.2016.02.010 S0049-3848(16)30037-8 Chronic inflammatory diseases predispose for development of a first pulmonary embolism (PE). Previous studies showed that corticosteroids, which are the mainstay of treatment (...) for inflammatory diseases, enhance the risk of a first venous thromboembolism. Yet, it is unknown whether corticosteroids also predispose for recurrent events. Therefore, we investigated the association between oral and/or inhaled corticosteroid use and the risk of recurrent PE. We performed a nested case-control study using the PHARMO Database. Adult patients who had suffered from a first PE for which vitamin K antagonists were prescribed, were eligible. Of these, 384 patients with recurrent PE were matched

EvidenceUpdates2016

133. Polymyalgia rheumatica: observations of disease evolution without corticosteroid treatment

Polymyalgia rheumatica: observations of disease evolution without corticosteroid treatment 27843369 2018 11 13 1179-156X 8 2016 Open access rheumatology : research and reviews Open Access Rheumatol Polymyalgia rheumatica: observations of disease evolution without corticosteroid treatment. 45-49 The diagnostic diversity of polymyalgia rheumatica (PMR) can easily be obscured by the widespread use of corticosteroids (CSs) early in the disease course. This study observed the course of PMR without (...) , Long Branch, NJ, USA. eng Journal Article 2016 04 01 New Zealand Open Access Rheumatol 101688698 1179-156X corticosteroids polymyalgia rheumatica rheumatoid arthritis The author reports no conflicts of interest in this work. There has been no financial support, grants, or any other benefits from any commercial source for the work reported in this manuscript. 2016 11 16 6 0 2016 11 16 6 0 2016 11 16 6 1 epublish 27843369 10.2147/OARRR.S101911 oarrr-8-045 PMC5098760 J Rheumatol. 1992 Feb;19(2):270-2

Open access rheumatology : research and reviews2016 Full Text: Link to full Text with Trip Pro

134. Randomized controlled trial: Ultrasound-guided corticosteroid injections for adhesive capsulitis more effective than placebo

Randomized controlled trial: Ultrasound-guided corticosteroid injections for adhesive capsulitis more effective than placebo Ultrasound-guided corticosteroid injections for adhesive capsulitis more effective than placebo | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password (...) ? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Ultrasound-guided corticosteroid injections for adhesive capsulitis more effective than placebo Article Text Therapeutics/Prevention Randomized controlled trial Ultrasound-guided corticosteroid injections for adhesive capsulitis more effective than placebo Constance Marie Lebrun

Evidence-Based Medicine (Requires free registration)2016

135. Systematic review: Best evidence supports topical corticosteroids and routine saline irrigations for medical treatment of chronic rhinosinusitis

Systematic review: Best evidence supports topical corticosteroids and routine saline irrigations for medical treatment of chronic rhinosinusitis Best evidence supports topical corticosteroids and routine saline irrigations for medical treatment of chronic rhinosinusitis | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts (...) Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Best evidence supports topical corticosteroids and routine saline irrigations for medical treatment of chronic rhinosinusitis Article Text Therapeutics/Prevention Systematic review Best evidence supports topical corticosteroids and

Evidence-Based Medicine (Requires free registration)2016

136. Systematic review with meta analysis: Adjunctive corticosteroids improve the need for mechanical ventilation and shorten hospital duration in patients hospitalised with community-acquired pneumonia

Systematic review with meta analysis: Adjunctive corticosteroids improve the need for mechanical ventilation and shorten hospital duration in patients hospitalised with community-acquired pneumonia Adjunctive corticosteroids improve the need for mechanical ventilation and shorten hospital duration in patients hospitalised with community-acquired pneumonia | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your (...) username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Adjunctive corticosteroids improve the need for mechanical ventilation and shorten hospital duration in patients hospitalised with community-acquired

Evidence-Based Medicine (Requires free registration)2016

137. Do Systemic Corticosteroids Improve Outcomes in Chronic Obstructive Pulmonary Disease Exacerbations?

Do Systemic Corticosteroids Improve Outcomes in Chronic Obstructive Pulmonary Disease Exacerbations? DEFINE_ME_WA This site requires Cookies to be enabled to function. Please ensure Cookies are turned on and then re-visit the desired page.

Annals of Emergency Medicine Systematic Review Snapshots2016

138. Do Corticosteroids Provide Benefit to Patients With Community-Acquired Pneumonia?

Do Corticosteroids Provide Benefit to Patients With Community-Acquired Pneumonia? DEFINE_ME_WA This site requires Cookies to be enabled to function. Please ensure Cookies are turned on and then re-visit the desired page.

Annals of Emergency Medicine Systematic Review Snapshots2016

139. Corticosteroid treatment of duchenne muscular dystrophy

Corticosteroid treatment of duchenne muscular dystrophy Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy | Neurology Advertisement Search for this keyword Main menu User menu Search Search for this keyword The most widely read and highly cited peer-reviewed neurology journal Share February 02, 2016 ; 86 (5) Special Article Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy Report of the Guideline Development (...) .), Loma Linda University Medical Center, CA; and Departments of Pediatric and Neurology/Neurosurgery (M.O.), McGill University, Montréal, Canada. Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy David Gloss , Richard T. Moxley , Stephen Ashwal , Maryam Oskoui Neurology Feb 2016, 86 (5) 465-472; DOI: 10.1212/WNL.0000000000002337 Citation Manager Formats Downloads 4699 Share Abstract Objective: To update the 2005 American Academy of Neurology (AAN) guideline

American Academy of Neurology2016

140. Prescribing for rheumatological conditions in pregnancy and breastfeeding - Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids.

Prescribing for rheumatological conditions in pregnancy and breastfeeding - Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding—Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids | Rheumatology | Oxford Academic '); } We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies (...) . You can change your cookie settings at any time. Search Account Menu Menu Navbar Search Filter Mobile Microsite Search Term search filter search input Article Navigation Close mobile search navigation Article navigation September 2016 Article Contents Article Navigation BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding—Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids Julia Flint 1 Centre for Rheumatology Research, UCL Division

British Society for Rheumatology2016